Narrowband ultraviolet B treatment for psoriasis is highly economical and causes significant savings in cost for topical treatments.

K BoswellH CameronJ WestC FlemingSally Helen Ibbotson Robert S Dawe John Foerster

Published in: The British journal of dermatology (2018)

NB-UVB is a low-cost treatment; cost figures currently used in health technology appraisals are an overestimate based on the data presented here. Creating or extending access to NB-UVB is likely to offer additional savings by delaying or avoiding costly third-line treatments for many patients.

Keyphrases

low cost
end stage renal disease
healthcare
public health
chronic kidney disease
ejection fraction
electronic health record
machine learning
replacement therapy
patient reported outcomes
social media
wound healing